Cara Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Cassava Sciences USD 8.96M 3.99M 2024-12
Chugai Pharma JPY 23.24B 9.18B 2025-03
Cipla INR 12.33B 354.8M 2025-03
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.37M 361K 2024-12
CSL USD 1.18B 201M 2024-12
Grifols EUR 269.48M 49.95M 2024-12
Halozyme Therapeutics USD 42.36M 113K 2025-03
J&J USD 5.11B 1.34B 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
RedHill Biopharma USD 4.48M 1.52M 2024-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Cara Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.